Sense and nonsense in sensors

Continuous subcutaneous glucose monitoring (CGM) is a developing technology in the treatment of diabetes mellitus. The first randomised controlled trials on its efficacy have been performed. In several studies, CGM lowered HbA(1c) in adult patients with suboptimally controlled type 1 diabetes mellit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hermanides, J., DeVries, J. H.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2830625/
https://www.ncbi.nlm.nih.gov/pubmed/20225392
http://dx.doi.org/10.1007/s00125-009-1649-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2830625/
https://www.ncbi.nlm.nih.gov/pubmed/20225392
http://dx.doi.org/10.1007/s00125-009-1649-4

Ejemplares similares